nach oben

Erschienen in:

01.06.2019 | Case report

Dextromethorphan

Headache: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a study involving 12 patients, one adult patient [sex and exact age not stated] was described, who experienced headache while receiving dextromethorphan [dextromethorphan hydrobromide]. The patient was scheduled to receive oral dextromethorphan capsule 100 mg/70kg, 200 mg/70kg, 300 mg/70kg and 400 mg/70kg [frequency not stated; indication not clearly stated]. The patient also received triazolam concomitantly. Susbequently, the patient experienced headache secondary to dextromethorphan [duration of treatment to reaction onset and outcome not stated]. …

Reissig CJ, et al. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology 223: 1-15, No. 1, Sep 2012. Available from: URL: http://doi.org/10.1007/s00213-012-2680-6 - USA

Titel: Dextromethorphan
Headache: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63986-7

Springer Medizin

Dextromethorphan

Headache: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Diclofenamide

Methotrexate

Denosumab

Antineoplastics

Nivolumab

Thiamazole

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Diclofenamide

Methotrexate

Denosumab

Antineoplastics

Nivolumab

Thiamazole